Symbol: |
NCAN
|
Description: |
neurocan [Source:HGNC Symbol;Acc:2465]
|
Location: |
Chr19:19322782-19363061[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:119
Gene |
Compound |
Gen_sig |
Exp_pattern |
NCAN |
NSC 604979 |
0.006 |
Down |
NCAN |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.011 |
Down |
NCAN |
Naphtho[2,3-d]thiazole-4,9-dione, 2-[(4-nitrophenyl) amino]- |
0.009 |
Down |
NCAN |
Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride |
0.023 |
Down |
NCAN |
Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride |
0.032 |
Down |
NCAN |
NSC 643836 |
0.017 |
Down |
NCAN |
NSC 651337 |
0.002 |
Down |
NCAN |
NSC 651593 |
0.045 |
Down |
NCAN |
NSC 652536 |
0.017 |
Down |
NCAN |
Nitrotolazoline |
0.015 |
Down |
NCAN |
NSC 664264 |
0.028 |
Down |
NCAN |
Ethanamine, N,N-dimethyl-2-[4-(1,1-dimethylethyl)- 1-[(4-methylphenyl)methyl]cyclohexyloxy]-, (trans)-, (E)-2-butenedioate (fumaric acid) (1:1) |
0.011 |
Down |
NCAN |
NSC 672655 |
0.034 |
Down |
NCAN |
NSC 673352 |
0.001 |
Down |
NCAN |
2-Ethylaminoestradiol |
0.016 |
Down |
Expression pattern: Sensitivity / Resistance
Total:8 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:44
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:5
Gene |
Gen_transcript |
miRNA |
miR_location |
NCAN |
ENST00000252575 |
hsa-mir-18b-3p |
ChrX:133304072-133304093[-] |
NCAN |
ENST00000252575 |
hsa-mir-501-3p |
ChrX:49774380-49774401[+] |
NCAN |
ENST00000252575 |
hsa-mir-517c-3p |
Chr19:54244623-54244644[+] |
NCAN |
ENST00000252575 |
hsa-mir-553 |
Chr1:100746812-100746832[+] |
NCAN |
ENST00000252575 |
hsa-mir-574-3p |
Chr4:38869713-38869734[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|